UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 19, 2015
MEDIFIRST SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
| Nevada | | 333-178825 | | 27-3888260 |
| State or other jurisdiction | | Commission File Number | | IRS Employer |
| incorporation | | | | Identification No. |
| 4400 Route 9 South, Suite 1000, Freehold, NJ | | 07728 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant's telephone number, including area code: (732)-786-8044
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| Section 5- | Corporate Governance and Management |
| Item5.03 | Amendment to Articles of Incorporation or Bylaws; Change of Fiscal Year |
Effective November 19, 2015, the Company amended its Articles of Incorporation to increase its authorized capital to 1,500,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. All other provisions of the Articles of Incorporation in effect prior to this amendment remained unchanged.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this amended report to be signed on its behalf by the undersigned hereunto duly authorized.
| MEDIFIRST SOLUTIONS, INC. |
| | | |
| Dated: November 23, 2015 | By: | /s/ Bruce Schoengood |
| | President and Chief Executive Officer |
| Exhibit 16.1 | Letter from David A. Aronson, CPA, P.A., pursuant to Item 304 of Regulation S-K |
4
